Efficacy Archives - Lachman Consultant Services, Inc.

Say Goodbye to Ciprofloxacin 100mg Tablets!

By Bob Pollock Dec 07, 2023 ANDAs Efficacy Generics NDA OGD

An FDA notice contained in the Federal Register (FR) notice prepublication pages today (here) has put the final kibosh on the use of ciprofloxacin 100mg tablets due to current evidence demonstrating that the increased resistance of Escherichia coli (E. coli) to the low strength of ciprofloxacin makes it no longer effective for treatment of acute […]

Jul

Just When you Thought it Was Safe to Come out of the Compounding Hood: Apparent Dearth of Evidence for the Effectiveness & Safety of Compounded Bioidentical Hormone Therapy

By Roy Sturgeon, PhD. Jul 08, 2020 Compliance Compounders Compounding Efficacy Safety

In late 2018, FDA entered a contract with the National Academies of Sciences, Engineering, and Medicine (the National Academies) to examine the clinical utility (effectiveness), safety and uses of compounded bioidentical hormone therapy (cBHT). A high-level committee was formed and examined in detail the clinical utility of cBHT drug preparations, especially those containing estradiol, estrone, […]

Efficacy

Say Goodbye to Ciprofloxacin 100mg Tablets!

Just When you Thought it Was Safe to Come out of the Compounding Hood: Apparent Dearth of Evidence for the Effectiveness & Safety of Compounded Bioidentical Hormone Therapy

Subscribe to our blog

Recent Articles

Contact Us: